BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 19737996)

  • 21. Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
    Pistulli R; Oberle V; Figulla HR; Yilmaz A; Pfeifer R
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):76-8. PubMed ID: 21076279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The management of patients with heparin-induced thrombocytopenia].
    Pötzsch B; Madlener K
    Hamostaseologie; 2006 Jan; 26(1):22-6. PubMed ID: 16444318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.
    Willenborg KL
    Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New concepts in heparin-induced thrombocytopenia: diagnosis and management.
    Spinler SA
    J Thromb Thrombolysis; 2006 Feb; 21(1):17-21. PubMed ID: 16475037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
    Warkentin TE
    Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux.
    Miranda AC; Donovan JL; Tran MT; Gore JM
    J Thromb Thrombolysis; 2012 Jan; 33(1):133-5. PubMed ID: 21947717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: a review.
    Girolami B; Girolami A
    Semin Thromb Hemost; 2006 Nov; 32(8):803-9. PubMed ID: 17171593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fondaparinux: a potential new therapy for HIT.
    Kuo KH; Kovacs MJ
    Hematology; 2005 Aug; 10(4):271-5. PubMed ID: 16085538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
    Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
    Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
    J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agents for the treatment of heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2010 Aug; 24(4):755-75, ix. PubMed ID: 20659659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardizing the management of heparin-induced thrombocytopenia.
    Fugate S; Chiappe J
    Am J Health Syst Pharm; 2008 Feb; 65(4):334-9. PubMed ID: 18238772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
    He Y; He H; Liu D; Long Y; Su L; Cheng W
    Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin induced thrombocytopenia: diagnosis and management.
    Alaraj A; Wallace A; Tesoro E; Ruland S; Amin-Hanjani S; Charbel FT; Aletich V
    J Neurointerv Surg; 2010 Dec; 2(4):371-8. PubMed ID: 21990651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update.
    Greinacher A; Warkentin TE
    Thromb Res; 2006; 118(2):165-76. PubMed ID: 16139874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin induced thrombocytopenia.
    Gupta S; Gupta MM
    J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.